CD274 and neoplasm: In a first prototypical phase, the service provides validation of AI apps for PD-L1 immunohistochemistry (IHC) on WSIs in non-small cell lung cancer (NSCLC), detecting positive and negative tumor cells and calculating the Tumor Proportion Score (TPS).